BiotecVisions 2012, March

Allison Goldstein,Andrew D. Moore,Adrian Miller,Barbara Janssens,Brian Mullen,Felicity Howlett,Frances J. Harding,Jing Zhu,Meghana Hemphill,Susan Vice,Vicci Parr,Péter L. Lakatos
DOI: https://doi.org/10.1002/biot.201200050
2012-01-01
Biotechnology Journal
Abstract:Nanoparticles for transcutaneous vaccinationCould nanotechnology prevent onethird of all deaths caused by infections?Many of these deaths are due to the lack of efficient prophylaxis and treatment options owing to the unavailability of vaccines and antibiotics or due to the development of drug resistances.Thus, it is of upmost importance to develop strategies for preventing and treating infectious diseases.In this mini-review in Microbial Biotechnology, the authors argue that there is no doubt that nanotechnology holds great promise for vaccination and especially transcutaneous immunization.Key issues that will have to be solved in the future are how nano delivery devices can transport a sufficient dose of the vaccine across the SC and how this can be achieved without opening the skin barrier for the invasion of pathogens or harmful material.Currently, ultra-flexible liposomes are the best investigated carriers in this aspect./feh
What problem does this paper attempt to address?